Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Revenue | $785.0M | $647.0M | $791.0M | $901.0M |
| Cost of revenue | $140.0M | $97.0M | $127.0M | $159.0M |
| Gross profit | $645.0M | $550.0M | $664.0M | $742.0M |
| Gross margin | 82.2% | 85.0% | 83.9% | 82.4% |
| R&D | $53.0M | $40.0M | $52.0M | $72.0M |
| Operating income | $178.0M | −$156.0M | $213.0M | −$91.0M |
| EBITDA | $230.0M | −$121.0M | $239.0M | −$51.0M |
| Net income | $134.0M | −$148.0M | $205.0M | −$53.0M |
| Net margin | 17.1% | -22.9% | 25.9% | -5.9% |
| EPS (diluted) | 0.90 | -0.96 | 1.35 | -0.36 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds INVVY.
No tracked institution reports a position in INVVY as of their last filing.
No one on the platform has traded INVVY yet.
| +0.00% |
| $5.7B |
| — |
| KARBFKaro Pharma AB (publ) | $5.25 | +0.00% | $1.5B | — |
| MITPFMithra Pharmaceuticals S.A. | $23.90 | +254.07% | $1.6B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$INVVY I suspect a dental decay lawsuit is a real possibility. Other scandals in the near future are possible as well. Respectfully, I’m being cautious here and reducing position by 90%.
View on StockTwits ↗Indivior PLC Files SEC Form 6-K $INVVY https://www.marketbeat.com/stocks/OTCMKTS/INVVY/sec-filings/
View on StockTwits ↗Indivior PLC Files SEC Form 6-K $INVVY https://www.marketbeat.com/stocks/OTCMKTS/INVVY/sec-filings/
View on StockTwits ↗Indivior PLC Files SEC Form 6-K $INVVY https://www.marketbeat.com/stocks/OTCMKTS/INVVY/sec-filings/
View on StockTwits ↗Indivior PLC Files SEC Form 6-K $INVVY https://www.marketbeat.com/stocks/OTCMKTS/INVVY/sec-filings/
View on StockTwits ↗Indivior PLC Files SEC Form 6-K $INVVY https://www.marketbeat.com/stocks/OTCMKTS/INVVY/sec-filings/
View on StockTwits ↗Indivior PLC Files SEC Form 6-K $INVVY https://www.marketbeat.com/stocks/OTCMKTS/INVVY/sec-filings/
View on StockTwits ↗Indivior PLC Files SEC Form 6-K $INVVY https://www.marketbeat.com/stocks/OTCMKTS/INVVY/sec-filings/
View on StockTwits ↗Indivior PLC Files SEC Form 6-K $INVVY https://www.marketbeat.com/stocks/OTCMKTS/INVVY/sec-filings/
View on StockTwits ↗Indivior PLC Files SEC Form 6-K $INVVY https://www.marketbeat.com/stocks/OTCMKTS/INVVY/sec-filings/
View on StockTwits ↗Indivior PLC Files SEC Form 6-K $INVVY https://www.marketbeat.com/stocks/OTCMKTS/INVVY/sec-filings/
View on StockTwits ↗Indivior PLC Files SEC Form 6-K $INVVY https://www.marketbeat.com/stocks/OTCMKTS/INVVY/sec-filings/
View on StockTwits ↗$INVVY $INDV Indivior Announces Q3 2023 Financial Results https://www.stocktitan.net/news/INVVY/indivior-announces-q3-2023-financial-w0r2levkashm.html
View on StockTwits ↗$INVVY $INDV Indivior Enters an Exclusive Licensing Agreement with Alar Pharmaceuticals https://www.stocktitan.net/news/INVVY/indivior-enters-an-exclusive-licensing-agreement-with-alar-4vzblq050zs9.html
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.